Biogenic Synthesis of Nanoparticles and Sustainable Nanotherapeutics

個数:1
紙書籍版価格
¥48,009
  • 電子書籍

Biogenic Synthesis of Nanoparticles and Sustainable Nanotherapeutics

  • 著者名:Das, Malay K. (EDT)
  • 価格 ¥30,537 (本体¥27,761)
  • Wiley(2026/03/10発売)
  • ポイント 277pt (実際に付与されるポイントはご注文内容確認画面でご確認下さい)
  • 言語:ENG
  • ISBN:9781394311309
  • eISBN:9781394311316

ファイル: /

Description

Biogenic nanotechnology in medicine, drug delivery, and public health and wellbeing

Biogenic Synthesis of Nanoparticles and Sustainable Nanotherapeutics presents a comprehensive exploration of natural bioresources used in the biogenic synthesis of nanoparticles and their sustainable applications in medicine, drug delivery, and public health and wellbeing. It covers 15 topics, ranging from trends in biogenic sustainable nanotechnology to the market outlook of biogenic nanopharmaceutical products.

Biogenic Synthesis of Nanoparticles and Sustainable Nanotherapeutics discusses:

  • Biogenic synthesis of nanoparticles by plant extract, plant latex, bacteria, fungi, microalgae, actinomycetes, yeast, viruses, onions, oranges and eggs
  • Characterization, safety assessment, patents, and clinical evidences of biogenic nanoparticles, including sustainable nanotherapeutics for application in human diseases
  • Green toxicology and safety assessment of biogenic nanoparticles
  • Trends in biogenic sustainable nanotechnology

Biogenic Synthesis of Nanoparticles and Sustainable Nanotherapeutics serves as a valuable resource for researchers, teachers, and students interested in green nanotechnology and sustainable nanopharmaceutical products.

Table of Contents

List of Contributors xix
Preface xxvii

1 Trends in Biogenic Sustainable Nanotechnology 1
Taison Jamatia, Malay K. Das, Evarin Debbarma, Rishav Mazumder, Ichu Daule, and Giles Mary Basumatary

1.1 Introduction 1
1.2 Approaches for the Synthesis of Nanomaterials 3
1.3 Biogenic Synthesis for Sustainable Nanotechnology 6
1.4 Application of Biogenic Sustainable Nanotechnology 18
1.5 Conclusion and Future Aspects 22

2 Biogenic Synthesis of Nanoparticles by Plant Extract and Green Nanotherapeutics 39
L. Ronibala Singha, Punamjyoti Das, Abirami Raja, Pallabi Borah, Rachna Sharma, Rajlakshmi Gogoi, and Malay K. Das

2.1 Introduction 39
2.2 Basic Mechanism Involved in Biogenic Synthesis of Nanoparticles from Plant Source 42
2.3 Biogenic Synthesis of Nanoparticles by Plant Source 42
2.4 Challenges Associated with Plant Extract-Based Biogenic Nanoparticles 51
2.5 Clinical Translation of Green Nanotherapeutics 52
2.6 Conclusion and Future Perspectives 64

3 Biogenic Synthesis of Nanoparticles by Plant Latex and Green Nanotherapeutics 75
Bapan Banik, Nikita Dey, Barnali Gogoi, and Malay K. Das

3.1 Introduction 75
3.2 Plants in Nanoparticle Synthesis 76
3.3 Biogenic Production of Nanoparticles from Plant Components 77
3.4 Latex as a Source for Nanoparticle Synthesis 82
3.5 Factors Affecting the Latex-Mediated Synthesis of Metallic Nanoparticles 84
3.6 Latex-Mediated Green Nanotherapeutics and Their Applications 86
3.7 Patents Linked to Latex-Mediated Nanoparticles 87
3.8 Conclusion and Future Perspective 87

4 Biological Synthesis of Nanoparticles by Bacteria and Biogenic Sustainable Nanotherapeutics 99
Junmoni Nath, Bhanu P. Sahu, and Malay K. Das

4.1 Introduction 99
4.2 Mechanisms of Nanoparticle Synthesis by Bacteria 100
4.3 Influence of Environmental Factors 103
4.4 Types of Nanoparticles Synthesized by Bacteria 104
4.5 Biogenic Nanoparticles in Sustainable Nanotherapeutics and Its
4.6 Advantages of Bacterial Nanoparticle Synthesis 112
4.7 Future Perspectives 113
4.8 Conclusion 114

5 Biological Synthesis of Nanoparticles by Fungi and Biogenic Sustainable Nanotherapeutics 127
Jyoti Kumari Mishra, Jack Patgiri, Priyanka Das, Moumita Gope, and Malay K. Das

5.1 Introduction 127
5.2 Fungi and the Biogenic Synthesis of Nanoparticles 130
5.3 Mechanism of Fungi-Mediated Nanoparticle Synthesis 130
5.4 Factors Influencing the Synthesis of Fungi-Mediated Nanoparticles 134
5.5 Life Cycle Assessment and Toxicity of Fungal-Derived Nanoparticles 136
5.6 Sustainability and Green Chemistry Aspects of Fungi-Mediated Nanoparticles 138
5.7 Challenges and Limitations 139
5.8 Future Perspective 140
5.9 Conclusion 140

6 Biological Synthesis of Nanoparticles by Microalgae and Biogenic Sustainable Nanotherapeutics 145
Ranu Biswas, Md Ahesan Ansari, Arjun Kumar Sen, and Emdad Hossain

6.1 About Algae and their Use 145
6.2 Spectrum of Algae-Mediated Nanoparticle's Green Synthesis 146
6.3 Pathway of NPs Biosynthesis Mediated by Algae 147
6.4 Critical Review on Synthesis of Various NPs Using Various Algae 149
6.5 Application of Algae-Based Nanoparticles 151
6.6 Algae-Mediated Biogenic Nanotherapeutics: Pre-Clinical and Clinical Evidences 156
6.7 Challenges 158
6.8 Conclusion and Future Perspectives 159

7 Biological Synthesis of Nanoparticles by Actinomycetes and Biogenic Sustainable Nanotherapeutics 165
Pratap Kalita, Abhinab Goswami, Malay K. Das, and Lalduhsanga Pachuau

7.1 Introduction 165
7.2 Biosynthesis of Metallic Nanoparticles by Actinomycetes 167
7.3 Characterization of Actinomycetes-Assisted Nanoparticles 171
7.4 Application of Biogenic Nanoparticles 175
7.5 Conclusion 185

8 Biological Synthesis of Nanoparticles by Yeast and Biogenic Sustainable Nanotherapeutics 193
Balisa Mosisa Ejeta, Malay K. Das, F. F. Bekere, and O. T. Ayana

8.1 Introduction 193
8.2 Mechanism of Yeast-Mediated Nanoparticle Synthesis 199
8.3 Characterization of Nanoparticles Synthesized by Yeast 206
8.4 Biomedical Applications of Yeast-Synthesized Nanoparticles 210
8.5 Clinical Evidences of Biogenic Nanotherapeutics 214
8.6 Sustainability and Environmental Impacts 216
8.7 Future of Sustainable Biogenic Nanomedicine 219
8.8 Future Prospects and Challenges 219
8.9 Conclusion 222

9 Biological Synthesis of Nanoparticles by Viruses and Biogenic Sustainable Nanotherapeutics 227
Hemanga Hazarika, Padmanath Pegu, Harshita Krishnatreyya, Naba Jyoti Kalita, and Ratan Chowdhury

9.1 Introduction 227
9.2 Role of Viruses in NP Synthesis 230
9.3 Metal NP Synthesis by Viruses 234
9.4 Virus-Derived NPs in Nanomedicine and Nanotherapeutics 236
9.5 Sustainable Aspects of Virus-Mediated Biogenic Production of Nanomaterials 240
9.6 Challenges and Prospects in Virus-Mediated Biogenic Synthesis of Nanoparticles 241
9.7 Conclusion 243

10 Synthesis of Biogenic Nanoparticles Using Onion and Biogenic Nanomedicine 255
Roohi Kesharwani, Shahnawaz Shameem, and Dilip K. Patel

10.1 Introduction 255
10.2 Approaches of Nanoparticle Synthesis 258
10.3 Mechanism for Synthesis of Onion Extract-Based Nanoparticles 262
10.4 Synthesis of Different Types Nanoparticle Containing Onion Extract 263
10.5 Conclusion 270

11 Biogenic Synthesis of Nanoparticles Using Orange and Green Nanomedicine 277
Bhupen Kalita, Malay K. Das, Fazid Ali, Nihalini Kalita, and Md. Latifur Rahman

11.1 Introduction 277
11.2 Biological Precursors 279
11.3 Mechanisms of Biogenic Nanoparticle Formation 282
11.4 Orange-Derived Nanoparticles and Their Applications 284
11.5 Patents and Commercialization of Orange-Derived Biogenic Nanoparticles 289
11.6 Challenges and Limitations in Orange-Mediated Biogenic Nanoparticle Synthesis 291
11.7 Research Gaps and Future Perspectives in Green Nanotechnology 293
11.8 Future Prospects of Orange-Mediated Green Nanotechnology 295
11.9 Conclusion 296

12 Sustainable Appproaches for the Synthesis of Biogenic Nanoparticles Using Egg and Biogenic Nanomedicine 307
Priyanka Das, Moumita Gope, Jyoti Kumari Mishra, Jack Patgiri, and Malay K. Das

12.1 Introduction 307
12.2 Egg and Biogenic Nanoparticles 308
12.3 General Egg-Based Nanoparticle Synthesis 310
12.4 Factors Affecting Egg-Based Nanoparticle Formation 312
12.5 Sustainability and Green Chemistry Aspects 315
12.6 Future Perspectives 316
12.7 Conclusion 316

13 An Overview of Recent Patents on Biogenic Nanopharmaceutical Products 321
Arindam Chatterjee, Pratap Kalita, Parveen Kumar, Raja Chakraborty, and Saikat Sen

13.1 Introduction 321
13.2 Biogenic Nanopharmaceuticals 323
13.3 Recent Advances in Biogenic Nanopharmaceutical Patents 328
13.4 Patent Categories and Innovations 331
13.5 Case Studies of Prominent Biogenic Nanopharmaceutical Patents 335
13.6 Challenges in Biogenic Nanopharmaceutical Patenting 343
13.7 Future Perspectives of Biogenic Nanoparticles 348
13.8 Conclusion 349

14 Green Toxicology and Safety Assessment of Biogenic Nanoparticles 361
Punam Talukdar, Ratul Chakraborty, Ayan Goswami, Chinmoyee Deori, and Asis Bala

14.1 Introduction 361
14.2 Biogenic Nanoparticles (BNPs) 362
14.3 Safety Assessment of Biogenic Nanoparticles 367
14.4 Factors Influencing BNP Toxicity 368
14.5 Regulatory Framework and Safety Guidelines 371
14.6 Case Studies 373
14.7 Challenges and Future Perspectives 375

15 Market Outlook for Biogenic Nanopharmaceutical Products 385
Himakshi Baruah, Anupam Sarma, Tapash Chakraborty, and Malay K. Das

15.1 Introduction 385
15.2 Classification 387
15.3 Limitations of Biogenic Nanoparticles 395
15.4 Current Industry Trends 396
15.5 Regulatory Aspects of Biogenic Nanoparticles 399
15.6 Global Forecast 400
15.7 Conclusion 402

References 402
Index 409

最近チェックした商品